Novel miR-5088-5p promotes malignancy of breast cancer by inhibiting DBC2.

Seok, Hyun Jeong; Choi, Young Eun; Choi, Jae Yeon; Yi, Joo Mi; Kim, Eun Joo; Choi, Mi Young; Lee, Su-Jae; Bae, In Hwa

Seok, Hyun Jeong; Choi, Young Eun; Choi, Jae Yeon; Yi, Joo Mi; Kim, Eun Joo; Choi, Mi Young; Lee, Su-Jae; Bae, In Hwa.

Afiliación

Seok HJ; Division of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea.
Choi YE; Division of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea.
Choi JY; Division of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea.
Yi JM; Department of Microbiology and Immunology, College of Medicine, Inje University, Busan, Republic of Korea.
Kim EJ; Division of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea.
Choi MY; Radiological & Medico-Oncological Sciences, University of Science and Technology, Daejeon, Republic of Korea.
Lee SJ; Department of Life Science, Hanyang University, Seoul, Republic of Korea.
Bae IH; Department of Life Science, Hanyang University, Seoul, Republic of Korea.

Mol Ther Nucleic Acids ; 25: 127-142, 2021 Sep 03.

Article en En | MEDLINE | ID: mdl-34457998

Palabras clave

DBC2; Fyn; metastasis; methylation; miR-5088-5p; tumorigenicity

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mol Ther Nucleic Acids Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google